In metabolic disease, polymorphisms at the ANRIL gene are linked to risk of type 2 diabetes, coronary artery disease, coronary artery calcium score, myocardial infarction, and stroke. Here, CDKN2B-AS1 is linked to type 2 diabetes mellitus.